logo
Plus   Neg
Share
Email

Novartis Reaches Licensing, Supply Agreement With Spark For LUXTURNA Outside US

Novartis (NVS) announced a licensing agreement with Spark Therapeutics covering development, registration and commercialization rights to voretigene neparvovec in markets outside the US. Novartis will make an upfront payment as well as pay milestones and royalties to Spark Therapeutics. The market authorization application with the European Medicines Agency was filed on July 31, 2017. Commercialization rights will be transferred to Novartis upon successful completion of registration and issuance of market authorization.

Voretigene neparvovec, known as LUXTURNA in the US, received FDA approval on December 19, 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65 (retinal pigment epithelial 65 kDa protein) gene. Spark Therapeutics retains exclusive rights for LUXTURNA in the US.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Luxury online marketplace Farfetch has filed for an initial public offering or IPO to list its shares in the U.S. Farfetch has filed a F-1 registration statement with the U.S. Securities and Exchange Commission. The London-based company plans to list its shares on the New York Stock Exchange under the ticker 'FTCH.' Media reports indicate that IPO could value the company at up to $5 billion. Apple Inc. has reportedly removed more than 25,000 illegal apps from its App Store in China after coming under intense criticism from Chinese state media for failing to ban illegal online content on its platform. According to various media reports, the iPhone maker removed these illegal apps as they sold fake lottery tickets and offered gambling services. Hundreds of Google employees signed a petition protesting the company's secret project to develop a censored version of its search engine for China. In a letter, posted by Buzzfeed and first reported by the New York Times, the employees said that work on the project and Google's return to China raises "urgent moral and ethical issues." Google is trying to keep a foothold in China.
Follow RTT